We postulate that elevated levels of Wnt5a during obesity (released from the VAT) may promote the development and growth of the aggressive squamous subtype of PDAC through YAP-mediated mechanisms, although further studies are needed to confirm this model. The gene discussed is WNT5A; the disease is Obesity.